| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-06 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 3e-05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |